Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on S Naproxen. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN87100031A reveals microbial hydrolysis for high-purity S-Naproxen. Enables cost reduction in pharmaceutical intermediate manufacturing and supply chain reliability.
Patent CN103467228A details a mild Pd-catalyzed allyl-aryl coupling for high-purity chiral intermediates, offering significant cost reduction in API manufacturing and robust supply chain reliability.
Patent CN102850204B details advanced chiral resolution for NSAIDs. Discover cost-effective manufacturing and reliable supply chain solutions for high-purity intermediates.
Patent CN102924206B details a ligand-free aqueous synthesis for high-purity pharmaceutical intermediates, offering significant cost reduction and supply chain reliability for global buyers.